Does inflammation help during COVID-19?

Persistent viral presence, rather than the early exaggerated inflammation, may be a key determinant of disease severity in #COVID19. If so, the focus of new therapies should be to promote viral clearance to decrease disease severity and mortality. https://bit.ly/3ahgzkP

Detalles Bibliográficos
Autores principales: Sharma, Lokesh, Chang, De, Dela Cruz, Charles S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553107/
https://www.ncbi.nlm.nih.gov/pubmed/33083436
http://dx.doi.org/10.1183/23120541.00557-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553107/
https://www.ncbi.nlm.nih.gov/pubmed/33083436
http://dx.doi.org/10.1183/23120541.00557-2020

Ejemplares similares